TY - JOUR
T1 - Elastic Tubing Resistance Training and Autonomic Modulation in Subjects with Chronic Obstructive Pulmonary Disease
AU - Ricci-Vitor, Ana Laura
AU - Vanderlei, Luiz Carlos M.
AU - Pastre, Carlos Marcelo
AU - Ramos, Dionei
AU - Ramos, Ercy Mara C.
AU - Ferreira Filho, Celso
AU - Ferreira, Celso
N1 - Publisher Copyright:
© 2018 Ana Laura Ricci-Vitor et al.
PY - 2018
Y1 - 2018
N2 - This study addresses evidence concerning elastic tubing resistance training (ET) on autonomic modulation in patients with chronic obstructive pulmonary disease (COPD). Autonomic dysfunction is common in COPD and contributes to the development of arrhythmias and sudden death. Along with autonomic dysfunction, muscle dysfunction is related to functional limitations and prognosis of the disease. This study investigated the effects of ET on autonomic modulation, muscle strength, and walking distance in COPD. Subjects were divided into two groups, ET (n=20; 66,5±8,9 y; 25,5±3,5 kg/m2; FEV1/FVC: 50,3±11,0) and conventional training (n=19; 66,0±6,9; 27,1±4,3; FEV1/FVC: 55,05±9,56). Both groups undertook 24 sessions for 60 minutes, 3 times in a week. The significance level was p ≤ 0,05. Autonomic modulation was evaluated using heart rate variability in the time (rMSSD, ms) and frequency domain (HF, ms). Strength for upper and lower limbs was measured using dynamometry and walking distance was measured using a 6-minute walking test. There were no significant differences in the outcomes between groups. There was an increment to rMSSD [(16,7±11,0 versus 20,8±14,9) versus (14,2±10,0 versus 17,4±12,1)], HF [(141,9±191,3 versus 234,9±335,7) versus (94,1±123,5 versus 177,6±275,5)], shoulder abduction [(50,1±19,6 versus 56,9±20,4) versus (50,5±19,0 versus 56,9±19,3)], knee flexion [(101,9±34,0 versus 116,8±43,3) versus (98,6±21,5 versus 115,1±30,8)], and walking test [(433,0±84,8 versus 468,9±90,8) versus (397,4±99,8 versus 426,3±101,6)] after training for ET and conventional training, respectively. In conclusion, ET improves autonomic modulation in COPD with additional benefits for strength and cardiorespiratory capacity similar to conventional training.
AB - This study addresses evidence concerning elastic tubing resistance training (ET) on autonomic modulation in patients with chronic obstructive pulmonary disease (COPD). Autonomic dysfunction is common in COPD and contributes to the development of arrhythmias and sudden death. Along with autonomic dysfunction, muscle dysfunction is related to functional limitations and prognosis of the disease. This study investigated the effects of ET on autonomic modulation, muscle strength, and walking distance in COPD. Subjects were divided into two groups, ET (n=20; 66,5±8,9 y; 25,5±3,5 kg/m2; FEV1/FVC: 50,3±11,0) and conventional training (n=19; 66,0±6,9; 27,1±4,3; FEV1/FVC: 55,05±9,56). Both groups undertook 24 sessions for 60 minutes, 3 times in a week. The significance level was p ≤ 0,05. Autonomic modulation was evaluated using heart rate variability in the time (rMSSD, ms) and frequency domain (HF, ms). Strength for upper and lower limbs was measured using dynamometry and walking distance was measured using a 6-minute walking test. There were no significant differences in the outcomes between groups. There was an increment to rMSSD [(16,7±11,0 versus 20,8±14,9) versus (14,2±10,0 versus 17,4±12,1)], HF [(141,9±191,3 versus 234,9±335,7) versus (94,1±123,5 versus 177,6±275,5)], shoulder abduction [(50,1±19,6 versus 56,9±20,4) versus (50,5±19,0 versus 56,9±19,3)], knee flexion [(101,9±34,0 versus 116,8±43,3) versus (98,6±21,5 versus 115,1±30,8)], and walking test [(433,0±84,8 versus 468,9±90,8) versus (397,4±99,8 versus 426,3±101,6)] after training for ET and conventional training, respectively. In conclusion, ET improves autonomic modulation in COPD with additional benefits for strength and cardiorespiratory capacity similar to conventional training.
UR - http://www.scopus.com/inward/record.url?scp=85048526765&partnerID=8YFLogxK
U2 - 10.1155/2018/9573630
DO - 10.1155/2018/9573630
M3 - Article
C2 - 30003108
AN - SCOPUS:85048526765
SN - 2314-6133
VL - 2018
JO - BioMed Research International
JF - BioMed Research International
M1 - 9573630
ER -